Genetic Dilated Cardiomyopathy: A Review
References
- Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor MRG, Mestroni L. Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine. Nature Rev Cardiol. 2025;22(3):183-198). doi: 10.1038/s41569-024-01074-2
- Jordan E, Peterson L, Ai T, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation. 2021 May 5;144(1);7-19. doi: 10.1161/CIRCULATIONAHA.120.053033
- Parikh VN, Day SM, Lakdawala NK, et al. Advances in the study and treatment of genetic cardiomyopathies. Cell. 2025 Feb 20;188(4):901-918. doi: 10.1016/j.cell.2025.01.011
- Merlo M, Setti M, Sinagra G. Coronary artery disease and dilated cardiomyopathy: Where parallel universes merge. Eur J Heart Fail. 2024 Jan;26(1):56-58. doi: 10.1002/ejhf.3095
- Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194
- Heymans S, Lakdawala NK, Tschöpe C, Klingel K. Dilated cardiomyopathy: causes mechanisms and current and future treatment approaches. Lancet. 2023;402(10406):998-1011. doi: 10.1016/S0140-6736(23)01241-2
- ClinGen [Internet. Bethesda, MD: The National Human Genome Research Institute; c2026.
ClinGen Variant & Gene Curation ; 2026 [cited 1016 Aug 5]. Available from:https://curation.clinicalgenome.org - ClinGen [Internet]. Bethesda, MD: The National Human Genome Research Institute; c2026.
Gene-Disease Validity Curation ; 2026 [cited 2026 Aug 5]. Available from:https://www.clinicalgenome.org/curation-activities/gene-disease-validity - Escobar-Lopez L, Ochoa JP, Mirelis JG, et al. Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy. J Am Coll Cardiol. 2021 Oct 26;78(17):1682-1699. doi: 10.1016/j.jacc.2021.08.039
- Goli R, Li J, Brandimarto J, et al. Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy. Circulation. 2021 May 11;143(19) 1852-1862. doi: 10.1161/CIRCULATIONAHA.120.052395
- Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation. 2019 Jul 2;140(1) 31-41. doi: 10.1161/CIRCULATIONAHA.118.037934
- Ware JS, Amor-Salamanca A, Tayal U, et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity. J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462
- Verdonschot JAJ, Hazebroek MR, Wang P, et al. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy. Circ Heart Fail. 2018 Nov;11(11):
e005220 . doi: 10.1161/CIRCHEARTFAILURE.118.005220 - Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy woolly hair and keratoderma. Hum Mol Genet. 2000 Nov 1;9(18):2761-2766. doi: 10.1093/hmg/9.18.2761
- Brandão M, Bariani R, Rigato I, Bauce B. Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity. J Clin Med. 2023 Apr 3;12(7):2660. doi: 10.3390/jcm12072660
- Verdonschot JAJ, Vanhoutte EK, Claes GRF, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Human Mutat. 2020 Jun;41(6):1091-1111. doi: 10.1002/humu.24004
- Sikking MA, Stroeks SLVM, Henkens MTHM, et al. Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy. J Clin Med. 2023 Jun 9;12(12):3937. doi: 10.3390/jcm12123937
- Martini M, Parodi A, Marinas MB, et al. Hot phase episodes in Arrhythmogenic cardiomyopathy: More than just a Desmoplakin issue? Hot-phase episodes in arrhythmogenic cardiomyopathy. Trends Cardiovasc Med. 2026 Aug;36(6):367-374. doi: 10.1016/j.tcm.2025.12.005
- Stroeks SLVM, Merlo M, Mora-Ayestaran N, et al. Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy. Circ Heart Fail. 2025 Nov;18(11):
e012592 . doi: 10.1161/CIRCHEARTFAILURE.124.012592 - van Rijsingen IAW, Arbustini E, Elliott P, et al. Risk factors for malignant ventricular arrhythmias in Lamin A/C mutation carriers: A European cohort study. J Am Coll Cardiol. 2012 Jan 31;59(5):493-500. doi: 10.1016/j.jacc.2011.08.078
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032). doi: 10.1161/CIR.0000000000001063
- Dellefave-Castillo LM, Cirino AL, Callis TE, et al. Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing. JAMA Cardiol. 2022 Sep 1;7(9):966-974. doi: 10.1001/jamacardio.2022.2455
- Balakrishnan ID, Lakdawala NK. Contemporary Insights into LMNA Cardiomyopathy. Curr Cardiol Rep. 2025 Jan 27;27(1):40. doi: 10.1007/s11886-025-02195-x
- Verstraelen TE, van Lint FH, Bosman LP, et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers- reaching the frontiers of individual risk prediction. Eur Heart J. 2021 Jul 31;42(29):2842-2850. doi: 10.1093/eurheartj/ehab294
- Manca P, Stolfo D, Merlo M, et al. Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2022 Jul;24(7):1171-1179. doi: 10.1002/ejhf.2512
- Køber L, Thune JJ, Nielsen JC, et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. New Engl J Med. 2016 Sep 29;375(13):1221-1230. doi: 10.1056/nejmoa1608029
- Sidhu K, Castrini AI, Parikh V, et al. The response to cardiac resynchronization therapy in LMNA cardiomyopathy. Eur J Heart Fail. 2022 Apr;24(4):685-693. doi: 10.1002/ejhf.2463
- Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies myocarditis and pericarditis: Position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019 Jan 1;40(1):19-33. doi: 10.1093/eurheartj/ehy730
- Khayata M, Al-Kindi SG, Oliveira G. Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. World J Cardiol. 2019 Jan 26;11(1):31-46. doi: 10.4330/wjc.v11.i1.38
- Teerlink JR, Diaz R, Felker GM, et al. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. New Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/nejmoa2025797
- Lakdawala NK, Hershberger RE, Garcia-Pavia P, et al. Danicamtiv a Selective Agonist of Cardiac Myosin for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial. J Am Coll Cardiol. 2025 Dec 23;86(25):2598-2612. doi: 10.1016/j.jacc.2025.09.1511
- Garcia-Pavia P, Rodriguez Palomares JF, Sinagra G, et al. REALM-DCM: A Phase 3 Multinational Randomized Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNARelated Dilated Cardiomyopathy. Circ Heart Fail. 2024 Jul;17(7):
e011548 . doi: 10.1161/CIRCHEARTFAILURE.123.011548 - Chen SN, Lam CK, Wan Y-W, et al. Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy. Sci Adv. 2022 Feb 25;8(8):
eabk0052 . doi: 10.1126/sciadv.abk0052 - Helms AS, Thompson AD, Day SM. Translation of New and Emerging Therapies for Genetic Cardiomyopathies. JACC Basic Transl Sci. 2021 Dec 1;7(1):70-83). doi: 10.1016/j.jacbts.2021.07.012
- Eldemire R, Mestroni L, Taylor MRG. Genetics of Dilated Cardiomyopathy. Annu Rev Med. 2024 Jan 29:75:417-426. doi: 10.1146/annurev-med-052422-020535
- Alqahtani A, Tulbah S, Alruwaili N, et al. Reduced Penetrance and Variable Expression of Dilated Cardiomyopathy Associated With Homozygous Truncating Variants in NRAP. Clin Genet. 2026 Mar;109(3):598-603. doi: 10.1111/cge.70078
- Phoon CKL, Halvorsen M, Goldstein DB, et al. Sudden unexpected death in asymptomatic infants due to PPA2 variants. Mol Genet Genomic Med. 2020 Jan;8(1):
e1008 . doi: 10.1002/mgg3.1008 - Amor-Salamanca A, Santana Rodríguez A, Rasoul H, et al. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction. Circ Genom Precis Med. 2024 Apr;17(2):
e004404 . doi: 10.1161/CIRCGEN.123.004404
DOI: https://doi.org/10.14797/mdcvj.1849 | Journal eISSN: 1947-6108
Language: English
Page range: 68 - 77
Submitted on: Apr 16, 2026
Accepted on: Jul 24, 2026
Published on: Sep 15, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2026 Madelyn Boslough, Matthew R.G. Taylor, Luisa Mestroni, Raffaela Lombardi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.